1. The present and future of biomarkers in prostate cancer: proteomics, genomics, and immunology advancements. Supplementary issue: biomarkers and their essential role in the development of personalised therapies (A);Gaudreau;Biomark Cancer,2016
2. Which is the most important risk factor for prostate cancer: race, family history, or baseline PSA level?;Mondo;J Urol,2008